---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-25-000048"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2025-10-10T23:59:59+00:00"
generated_at: "2026-05-17T04:08:02.402978+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Martha Aronson named CEO of Merit Medical as Fred Lampropoulos resigns; remains Chairman

## Summary
- Aronson appointed President and CEO effective Oct 3, 2025; Lampropoulos resigns as CEO but stays as director and Chairman.
- Aronson base salary $1M; signing bonus $250K; target bonus 100% of base; initial equity target $5.5M.
- Immediate equity grant of $4.125M in PSUs and RSUs; transition allowance $12K/month through Sep 2026.
- Lampropoulos serves as Executive Chairman through Jan 3, 2026, then non-employee director; consulting deal under negotiation.
- Board expanded from 10 to 11 to accommodate Aronson's appointment.

## SEC filing metadata
- accession: 0000856982-25-000048
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2025-10-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698225000048/0000856982-25-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698225000048/mmsi-20251003x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-25-000048
- JSON: https://secwatch.observer/filing/0000856982-25-000048.json
- Plain text: https://secwatch.observer/filing/0000856982-25-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.